Published in J Clin Microbiol on February 06, 2008
Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer (2012) 1.38
An overview of the clinical use of filter paper in the diagnosis of tropical diseases. Am J Trop Med Hyg (2013) 1.02
Primary treatment results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, Indonesia. PLoS One (2013) 0.93
Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies. Curr Opin HIV AIDS (2015) 0.93
Evaluation of biological sample preparation for immunosignature-based diagnostics. Clin Vaccine Immunol (2012) 0.93
Knowledge of general practitioners about nasopharyngeal cancer at the Puskesmas in Yogyakarta, Indonesia. BMC Med Educ (2010) 0.89
Two-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinoma. Clin Vaccine Immunol (2009) 0.86
Short-term effect of different teaching methods on nasopharyngeal carcinoma for general practitioners in Jakarta, Indonesia. PLoS One (2012) 0.85
Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma. J Cancer Res Clin Oncol (2015) 0.80
Complementary determination of Epstein-Barr virus DNA load and serum markers for nasopharyngeal carcinoma screening and early detection in individuals at risk in Tunisia. Eur Arch Otorhinolaryngol (2011) 0.80
Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus Zta IgA antibodies in human serum. Viral Immunol (2015) 0.75
Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening. PLoS One (2015) 0.75
Seroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area. PLoS One (2017) 0.75
Comparison of narrow-band imaging and conventional nasopharyngoscopy for the screening of unaffected members of families with nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol (2013) 0.75
A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. Pediatrics (1963) 14.49
Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol (2002) 4.27
Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr (2001) 3.85
Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1966) 3.56
Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer (1976) 3.36
Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples. JAMA (1991) 2.94
Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field. J Clin Microbiol (2001) 2.90
Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med (2001) 2.26
Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire. J Clin Microbiol (1992) 2.09
Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection. J Chromatogr (1983) 1.99
The use of the dried blood spot sample in epidemiological studies. J Clin Pathol (1999) 1.95
Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. Biochem Mol Med (1996) 1.72
Epstein-Barr virus antibodies in whole blood spots: a minimally invasive method for assessing an aspect of cell-mediated immunity. Psychosom Med (2000) 1.63
Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J Virol (1993) 1.55
Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int J Cancer (1985) 1.53
Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer (2004) 1.49
A quality assurance program for human immunodeficiency virus seropositivity screening of dried-blood spot specimens. Infect Control Hosp Epidemiol (1989) 1.47
Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma. Br J Cancer (2007) 1.45
Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein. J Infect Dis (1994) 1.44
EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies. Trends Microbiol (2004) 1.44
The ELISA guidebook. Methods Mol Biol (2000) 1.43
Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Int J Cancer (2006) 1.41
Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. J Infect Dis (2004) 1.38
Efficiency of reconstitution of immunoglobulin g from blood specimens dried on filter paper and utility in herpes simplex virus type-specific serology screening. Clin Diagn Lab Immunol (2002) 1.34
Persistence of human immunodeficiency virus type 1 subtype B DNA in dried-blood samples on FTA filter paper. J Clin Microbiol (2004) 1.27
Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer (1982) 1.24
Newborn screening for congenital infectious diseases. Emerg Infect Dis (2004) 1.21
Epstein-Barr virus specific marker molecules for early diagnosis of infectious mononucleosis. J Virol Methods (1988) 1.20
Validation of accuracy-based amino acid reference materials in dried-blood spots by tandem mass spectrometry for newborn screening assays. Clin Chem (1999) 1.19
Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia. J Clin Microbiol (2005) 1.18
Epitope-mapping on the Epstein-Barr virus major capsid protein using systematic synthesis of overlapping oligopeptides. J Virol Methods (1988) 1.17
Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden. J Clin Microbiol (2007) 1.15
Surveillance of measles in the Sudan using filter paper blood samples. J Med Virol (2004) 1.10
Dried venous blood samples for the detection and quantification of measles IgG using a commercial enzyme immunoassay. Bull World Health Organ (2003) 1.08
Comparison of available methods to elute serum from dried blood spot samples for measles serology. J Virol Methods (2006) 0.97
Commercial enzyme immunoassay adapted for the detection of antibodies to hepatitis C virus in dried blood spots. J Clin Virol (2006) 0.97
Enzyme immunoassay for total immunoglobulin E in dried blood spots. Am J Hum Biol (2007) 0.96
Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138. J Clin Microbiol (2001) 0.95
An evaluation of the use of dried blood spots from newborn screening for monitoring the prevalence of cocaine use among childbearing women. Biochem Mol Med (1997) 0.95
Screening for family members of patients with nasopharyngeal carcinoma. Int J Cancer (2005) 0.94
Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. J Med Virol (2005) 0.93
Epstein-Barr virus serology in early detection and screening of nasopharyngeal carcinoma. Ai Zheng (2006) 0.92
Multiprimed cDNA synthesis followed by PCR is the most suitable method for Epstein-Barr virus transcript analysis in small lymphoma biopsies. Mol Cell Probes (1997) 0.88
A simple method for collecting measured whole blood with quantitative recovery of antibody activities for serological surveys. J Immunol Methods (2007) 0.86
Epstein-Barr virus (EBV) serology for predicting distant metastases in a white juvenile patient with nasopharyngeal carcinoma and no clinical response to EBV lytic induction therapy. Head Neck (2006) 0.80
Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective? J Thromb Haemost (2011) 2.69
P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus. Virology (1997) 1.87
Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood (1997) 1.82
Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res (2000) 1.72
Association of innate immune activation with latent Epstein-Barr virus in active MS lesions. Neurology (2011) 1.70
Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 1.64
Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J Virol (1993) 1.55
Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins. J Virol (1993) 1.50
Human cytomegalovirus virions differentially incorporate viral and host cell RNA during the assembly process. J Virol (2000) 1.49
Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen. J Clin Microbiol (2001) 1.45
Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein. J Infect Dis (1994) 1.44
Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J Immunol (1998) 1.39
Iatrogenic perforation of intertwin membrane after laser surgery for twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol (2014) 1.38
K88-mediated binding of Escherichia coli outer membrane fragments to porcine intestinal epithelial cell brush borders. Infect Immun (1981) 1.35
Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J Immunol (2000) 1.30
Identification and molecular characterization of two diagnostically relevant marker proteins of the Epstein-Barr virus capsid antigen complex. J Med Virol (1993) 1.28
Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification. J Clin Microbiol (1998) 1.26
Monitoring of epstein-barr virus DNA load in peripheral blood by quantitative competitive PCR. J Clin Microbiol (1999) 1.12
Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification. J Clin Microbiol (1999) 1.10
A novel BRCA2 mutation in an Indonesian family found with a new, rapid, and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing. J Clin Pathol (2005) 1.08
The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation. Clin Exp Immunol (1985) 1.07
Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases. J Infect Dis (1999) 1.05
Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma. J Med Virol (1998) 1.01
Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas. J Clin Pathol (1997) 0.99
Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases. Mol Pathol (1999) 0.99
Early detection of human cytomegalovirus infection after kidney transplantation by nucleic acid sequence-based amplification. Transplantation (1999) 0.95
Human cytomegalovirus immediate-early messenger RNA in blood of pregnant women with primary infection and of congenitally infected newborns. J Infect Dis (2001) 0.95
Molecular fine-specificity analysis of antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays. J Clin Microbiol (1999) 0.94
Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. J Med Virol (2005) 0.93
Twin anemia-polycythemia sequence: diagnostic criteria, classification, perinatal management and outcome. Fetal Diagn Ther (2010) 0.93
Expression of epstein-barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV. J Clin Pathol (1996) 0.92
Killing of human cytomegalovirus-infected fibroblasts by antiviral antibody and complement. J Infect Dis (1986) 0.90
Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients. J Heart Lung Transplant (1998) 0.90
A randomised comparison of intravenous remifentanil patient-controlled analgesia with epidural ropivacaine/sufentanil during labour. Int J Obstet Anesth (2011) 0.90
Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease. J Pathol (2000) 0.89
Physical association between the EBV protein EBNA-1 and P32/TAP/hyaluronectin. J Biomed Sci (1998) 0.89
Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification. J Clin Microbiol (2000) 0.87
Genetic diversity: frameshift mechanisms alter coding of a gene (Epstein-Barr virus LF3 gene) that contains multiple 102-base-pair direct sequence repeats. Mol Cell Biol (2003) 0.87
Absence of elevated anti-alpha-synuclein and anti-EBV latent membrane protein antibodies in PD. Neurology (2002) 0.86
Production monitoring and purification of EBV encoded latent membrane protein 1 expressed and secreted by recombinant baculovirus infected insect cells. J Virol Methods (2000) 0.86
Detection of hepatitis C virus antigen by immuno-histochemical staining: a histological marker of hepatitis C virus infection. J Hepatol (1994) 0.85
Recovery of T cell subsets after autologous bone marrow transplantation is mainly due to proliferation of mature T cells in the graft. Blood (1985) 0.85
Development of an antibody-capture IgM-enzyme-linked immunosorbent assay for diagnosis of acute Epstein-Barr virus infections. J Virol Methods (1988) 0.85
An in vitro system to study interactions between bacteria and epithelial cells at the molecular level. J Gen Microbiol (1983) 0.84
Twin anemia-polycythemia sequence in two monochorionic twin pairs without oligo-polyhydramnios sequence. Placenta (2006) 0.83
Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR. J Clin Microbiol (1998) 0.83
Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients. Clin Vaccine Immunol (2010) 0.83
Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation. J Virol (2012) 0.82
Factor VIII levels and the risk of pre-eclampsia, HELLP syndrome, pregnancy related hypertension and severe intrauterine growth retardation. Thromb Res (2005) 0.82
Cytomegalovirus early and late membrane antigens detected by antibodies in human convalescent sera. J Virol (1985) 0.82
Expression of Epstein-Barr-virus-related nuclear antigens and B-cell markers in lymphomas of SIV-immunosuppressed monkeys. Int J Cancer (1993) 0.82
Immunofluorescence for detection of antibodies against human cytomegalovirus-induced membrane antigens. J Clin Microbiol (1986) 0.82
Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation. BJOG (2013) 0.81
Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients. J Infect Dis (2001) 0.80
Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection. Clin Exp Immunol (1985) 0.80
Direct quantification of human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic acid sequence-based amplification. J Clin Microbiol (2001) 0.80
Expression and analysis of the Epstein-Barr virus BARF1-encoded protein from a tetracycline-regulatable adenovirus system. Virus Res (2004) 0.80
Severe cerebral injury in a recipient with twin anemia-polycythemia sequence. Ultrasound Obstet Gynecol (2013) 0.79
Hematological characteristics in neonates with twin anemia-polycythemia sequence (TAPS). Prenat Diagn (2010) 0.79
Residual anastomoses after fetoscopic laser surgery in twin-to-twin transfusion syndrome: frequency, associated risks and outcome. Placenta (2006) 0.79
Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders. Mol Pathol (2001) 0.79
Prevalence, size, number and localization of vascular anastomoses in monochorionic placentas. Placenta (2013) 0.79
Evaluation of human cytomegalovirus gene expression in thoracic organ transplant recipients using nucleic acid sequence-based amplification. Transplantation (2000) 0.79
Laser surgery as a management option for twin anemia-polycythemia sequence. Ultrasound Obstet Gynecol (2014) 0.79
Early detection of cytomegalovirus in renal transplant recipients: comparison of PCR, NASBA, pp65 antigenemia, and viral culture. Transplant Proc (2000) 0.78
HLA-DRw6 as a risk factor for active cytomegalovirus but not for herpes simplex virus infection after renal allograft transplantation. Br Med J (Clin Res Ed) (1985) 0.78
Cytomegalovirus immunity in allogeneic marrow grafting. Transplantation (1985) 0.78
The effect of fetoscopic laser therapy on fetal cardiac size in twin-twin transfusion syndrome. Ultrasound Obstet Gynecol (2008) 0.77
Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines. Cell Immunol (2001) 0.77
Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. II. Secondary CMV infections associated with impaired in vitro proliferative responses to mitogens, allogeneic lymphocytes and CMV infected cells. Clin Exp Immunol (1985) 0.77
Is routine TORCH screening and urine CMV culture warranted in small for gestational age neonates? Early Hum Dev (2010) 0.77
Nucleic acid sequence-based amplification: a new technique for monitoring cytomegalovirus infection in transplant recipients. Transplant Proc (1999) 0.77
Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus. Clin Diagn Lab Immunol (1995) 0.77
Variable EBV DNA load distributions and heterogeneous EBV mRNA expression patterns in the circulation of solid organ versus stem cell transplant recipients. Clin Dev Immunol (2012) 0.77
Different profiles of cytomegalovirus RNA transcripts and anti-cytomegalovirus IgM antibodies in renal transplant recipients. J Clin Virol (2001) 0.77
Placental characteristics in growth-discordant monochorionic twins: a matched case-control study. Placenta (2011) 0.77
Bioreactor-scale production and one-step purification of Epstein-Barr nuclear antigen 1 expressed in baculovirus-infected insect cells. Protein Expr Purif (2000) 0.77
Evaluation of a new method for early detection of active cytomegalovirus infections. A study in kidney transplant recipients. Transpl Int (1998) 0.77
Management of twin anemia-polycythemia sequence using intrauterine blood transfusion for the donor and partial exchange transfusion for the recipient. Fetal Diagn Ther (2013) 0.76
Fetal cardiac output in monochorionic twins. Ultrasound Obstet Gynecol (2008) 0.76
Purification and quantification of recombinant Epstein-Barr viral glycoproteins gp350/220 from Chinese hamster ovary cells. J Chromatogr (1992) 0.76
All infiltrating T-lymphocytes in Hodgkin's disease express immunohistochemically detectable T-cell receptor zeta-chains in situ. Histopathology (2000) 0.76
Is Epstein-Barr virus present in the CNS of patients with MS? Neurology (2001) 0.76
You only find what you are looking for. BJOG (2007) 0.75
Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients. J Clin Virol (2002) 0.75
A worldwide survey of laser surgery for twin-twin transfusion syndrome. Ultrasound Obstet Gynecol (2014) 0.75
Assessment of feto-fetal transfusion flow through placental arterio-venous anastomoses in a unique case of twin-to-twin transfusion syndrome. Placenta (2006) 0.75
Placental characteristics in monochorionic twins with and without twin anemia-polycythemia sequence. Obstet Gynecol (2008) 0.75
Placental characteristics in monochorionic twins with spontaneous versus post-laser twin anemia-polycythemia sequence. Placenta (2013) 0.75
Perinatal outcome after selective feticide in monochorionic twin pregnancies. Ultrasound Obstet Gynecol (2013) 0.75
Hypoalbuminemia in donors with twin-twin transfusion syndrome. Fetal Diagn Ther (2012) 0.75
Laser surgery in twin-twin transfusion syndrome with proximate cord insertions. Placenta (2013) 0.75
TAPS and TOPS: two distinct forms of feto-fetal transfusion in monochorionic twins. Z Geburtshilfe Neonatol (2010) 0.75
A stimulatory role for cytomegalovirus (CMV) antibodies in CMV-specific lymphocyte proliferation in vitro. Intervirology (1983) 0.75
Identification of essential steps in laser procedure for twin-twin transfusion syndrome using the Delphi methodology: SILICONE study. Ultrasound Obstet Gynecol (2015) 0.75
Sensitive detection of cytomegalovirus infection in transplant recipients using nucleic acid sequence-based amplification. Transplant Proc (2000) 0.75